Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N S150 O95359 10579 TACC2 Rectum adenocarcinoma Phosphorylation N S150 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N T151 O95359 10579 TACC2 Rectum adenocarcinoma Phosphorylation N T151 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N S153 O95359 10579 TACC2 Rectum adenocarcinoma Phosphorylation N S153 O95359 10579 TACC2 Esophageal cancer Phosphorylation N S201 O95359 10579 TACC2 Colorectal cancer Phosphorylation N S269 O95359 10579 TACC2 Head and neck squamous cell carcinoma Phosphorylation N T324 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N T324 O95359 10579 TACC2 Head and neck squamous cell carcinoma Phosphorylation N S328 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N S328 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N S334 O95359 10579 TACC2 Skin cutaneous melanoma Phosphorylation N S334 O95359 10579 TACC2 Prostate adenocarcinoma Phosphorylation N T385 O95359 10579 TACC2 Prostate adenocarcinoma Phosphorylation N T392 O95359 10579 TACC2 Uterine corpus endometrial carcinoma Phosphorylation N S399 O95359 10579 TACC2 Ovarian cancer Phosphorylation N T411 O95359 10579 TACC2 Skin cutaneous melanoma Phosphorylation N T451 O95359 10579 TACC2 Skin cutaneous melanoma Phosphorylation N S455 O95359 10579 TACC2 Head and neck squamous cell carcinoma Phosphorylation N T533 O95359 10579 TACC2 Head and neck squamous cell carcinoma Phosphorylation N T536 O95359 10579 TACC2 Chondrosarcoma Phosphorylation N S561 O95359 10579 TACC2 Neuroendocrine tumor Phosphorylation N S575 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N S589 O95359 10579 TACC2 Stomach adenocarcinoma Phosphorylation N S589 O95359 10579 TACC2 Lung adenocarcinoma Phosphorylation N S590 O95359 10579 TACC2 Stomach adenocarcinoma Phosphorylation N S590 O95359 10579 TACC2 Lung squamous cell carcinoma Phosphorylation N S635 O95359 10579 TACC2 Lung squamous cell carcinoma Phosphorylation C S639 O95359 10579 TACC2 Lung squamous cell carcinoma Phosphorylation N S640 O95359 10579 TACC2 Lung squamous cell carcinoma Phosphorylation N S645 O95359 10579 TACC2 Lung squamous cell carcinoma Phosphorylation N S647 O95359 10579 TACC2 Bladder urothelial carcinoma Acetylation N K962 O95359 10579 TACC2 Brain lower grade glioma Acetylation N K962 O95359 10579 TACC2 Breast adenocarcinoma Acetylation N K962 O95359 10579 TACC2 Colon adenocarcinoma Acetylation N K962 O95359 10579 TACC2 Skin cutaneous melanoma Acetylation N K962 O95359 10579 TACC2 Urinary bladder cancer Phosphorylation N S962 O95359 10579 TACC2 Lung cancer Phosphorylation N S1025 O95359 10579 TACC2 Glioblastoma Phosphorylation N S1635 O95359 10579 TACC2 Stomach cancer Phosphorylation N T2246 O95359 10579 TACC2 Melanoma Phosphorylation N S2321 O95359 10579 TACC2 Pancreatic cancer Phosphorylation N S2512 P29992 2767 GNA11 GA11 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K52 P29992 2767 GNA11 GA11 Stomach adenocarcinoma Ubiquitination N K52 P29992 2767 GNA11 GA11 autosomal dominant hypocalcemia Ubiquitination N K57 P29992 2767 GNA11 GA11 Breast invasive carcinoma Ubiquitination N K133 P29992 2767 GNA11 GA11 Familial hypocalciuric hypercalcemia Ubiquitination N K133 P29992 2767 GNA11 GA11 Lung adenocarcinoma Ubiquitination N K133 P29992 2767 GNA11 GA11 Colon adenocarcinoma Ubiquitination N K158 P29992 2767 GNA11 GA11 Colon adenocarcinoma Phosphorylation N T162 P29992 2767 GNA11 GA11 Uveal melanoma Phosphorylation N T162 P29992 2767 GNA11 GA11 Hematologic cancer ADP-ribosylation N R183 P29992 2767 GNA11 GA11 Lung cancer ADP-ribosylation N R183 P29992 2767 GNA11 GA11 Melanoma ADP-ribosylation N R183 P29992 2767 GNA11 GA11 Neuroendocrine tumor ADP-ribosylation N R183 P29992 2767 GNA11 GA11 Melanoma Deamidation N Q209 P29992 2767 GNA11 GA11 Prostate cancer Deamidation N Q209 P29992 2767 GNA11 GA11 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K252 P29992 2767 GNA11 GA11 Ovarian serous cystadenocarcinoma Phosphorylation N Y291 P29992 2767 GNA11 GA11 Uterine corpus endometrial carcinoma Ubiquitination N K345 P29992 2767 GNA11 GA11 autosomal dominant hypocalcemia Ubiquitination N K345 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Head and neck squamous cell carcinoma Ubiquitination N K150 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Stomach adenocarcinoma Ubiquitination N K150 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Head and neck squamous cell carcinoma Ubiquitination N K186 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Skin cutaneous melanoma Phosphorylation N T324 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Lung adenocarcinoma Phosphorylation N S383 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Lung adenocarcinoma Acetylation N K385 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Lung adenocarcinoma Ubiquitination N K385 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Head and neck squamous cell carcinoma Ubiquitination N K503 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Kidney renal clear cell carcinoma Ubiquitination N K503 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Head and neck squamous cell carcinoma Ubiquitination N K512 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Kidney renal clear cell carcinoma Ubiquitination N K512 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Pheochromocytoma and Paraganglioma Phosphorylation N T528 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Neuroendocrine tumor Hydroxylation N P531 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Uterine cancer Hydroxylation N P531 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Skin cutaneous melanoma Phosphorylation N S672 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Stomach adenocarcinoma Phosphorylation N S672 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Bladder urothelial carcinoma Acetylation N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Breast invasive carcinoma Acetylation N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Invasive lobular carcinoma Acetylation N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Transitional cell carcinoma Acetylation N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Bladder urothelial carcinoma Ubiquitination N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Breast invasive carcinoma Ubiquitination N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Invasive lobular carcinoma Ubiquitination N K685 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Transitional cell carcinoma Ubiquitination N K685 Q9BV73 11190 CEP250 CEP2 CNAP1 Ovarian cancer Phosphorylation N S45 Q9BV73 11190 CEP250 CEP2 CNAP1 Stomach adenocarcinoma Phosphorylation N S45 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K75 Q9BV73 11190 CEP250 CEP2 CNAP1 Transitional cell carcinoma Ubiquitination N K75 Q9BV73 11190 CEP250 CEP2 CNAP1 Breast invasive carcinoma Ubiquitination N K132 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Ubiquitination N K167 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K206 Q9BV73 11190 CEP250 CEP2 CNAP1 Colon adenocarcinoma Ubiquitination N K206 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Phosphorylation N S264 Q9BV73 11190 CEP250 CEP2 CNAP1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K338 Q9BV73 11190 CEP250 CEP2 CNAP1 Glioblastoma multiforme Ubiquitination N K652 Q9BV73 11190 CEP250 CEP2 CNAP1 Lung adenocarcinoma Ubiquitination N K652 Q9BV73 11190 CEP250 CEP2 CNAP1 Lung squamous cell carcinoma Ubiquitination N K652 Q9BV73 11190 CEP250 CEP2 CNAP1 Lung adenocarcinoma Ubiquitination N K892 Q9BV73 11190 CEP250 CEP2 CNAP1 Uterine corpus endometrial carcinoma Ubiquitination N K956 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Ubiquitination N K1010 Q9BV73 11190 CEP250 CEP2 CNAP1 Breast invasive carcinoma Ubiquitination N K1016 Q9BV73 11190 CEP250 CEP2 CNAP1 Medulloblastoma Acetylation N K1048 Q9BV73 11190 CEP250 CEP2 CNAP1 Medulloblastoma Ubiquitination N K1048 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Phosphorylation N S1060 Q9BV73 11190 CEP250 CEP2 CNAP1 Brain lower grade glioma Phosphorylation N S1060 Q9BV73 11190 CEP250 CEP2 CNAP1 Medulloblastoma Phosphorylation N S1060 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K1148 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K1254 Q9BV73 11190 CEP250 CEP2 CNAP1 Colon adenocarcinoma Ubiquitination N K1254 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K1268 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Ubiquitination N K1268 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K1280 Q9BV73 11190 CEP250 CEP2 CNAP1 Thyroid carcinoma Ubiquitination N K1280 Q9BV73 11190 CEP250 CEP2 CNAP1 Stomach adenocarcinoma Phosphorylation N S1310 Q9BV73 11190 CEP250 CEP2 CNAP1 Stomach adenocarcinoma Phosphorylation N S1313 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Phosphorylation N S1324 Q9BV73 11190 CEP250 CEP2 CNAP1 Ovarian serous cystadenocarcinoma Ubiquitination N K1412 Q9BV73 11190 CEP250 CEP2 CNAP1 Ovarian serous cystadenocarcinoma Ubiquitination N K1417 Q9BV73 11190 CEP250 CEP2 CNAP1 Hepatocellular carcinoma Ubiquitination N K1466 Q9BV73 11190 CEP250 CEP2 CNAP1 Renal cell carcinoma Ubiquitination N K1484 Q9BV73 11190 CEP250 CEP2 CNAP1 Uterine corpus endometrial carcinoma Ubiquitination N K1502 Q9BV73 11190 CEP250 CEP2 CNAP1 Hepatocellular carcinoma Ubiquitination N K1533 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Ubiquitination N K1533 Q9BV73 11190 CEP250 CEP2 CNAP1 Stomach adenocarcinoma Ubiquitination N K1533 Q9BV73 11190 CEP250 CEP2 CNAP1 Prostate adenocarcinoma Ubiquitination N K1574 Q9BV73 11190 CEP250 CEP2 CNAP1 Prostate adenocarcinoma Ubiquitination N K1577 Q9BV73 11190 CEP250 CEP2 CNAP1 Breast invasive carcinoma Ubiquitination N K1679 Q9BV73 11190 CEP250 CEP2 CNAP1 Kidney renal papillary cell carcinoma Ubiquitination N K1679 Q9BV73 11190 CEP250 CEP2 CNAP1 Stomach adenocarcinoma Ubiquitination N K1689 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Phosphorylation N S1723 Q9BV73 11190 CEP250 CEP2 CNAP1 Hepatocellular carcinoma Phosphorylation N S1723 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K1797 Q9BV73 11190 CEP250 CEP2 CNAP1 Hepatocellular carcinoma Phosphorylation N S1927 Q9BV73 11190 CEP250 CEP2 CNAP1 Melanoma Phosphorylation N S1927 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Phosphorylation N S1927 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Ubiquitination N K1972 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Ubiquitination N K1980 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Phosphorylation N S2095 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Phosphorylation N S2095 Q9BV73 11190 CEP250 CEP2 CNAP1 Stomach adenocarcinoma Phosphorylation N S2143 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Phosphorylation N S2259 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Ubiquitination N K2265 Q9BV73 11190 CEP250 CEP2 CNAP1 Skin cutaneous melanoma Phosphorylation N S2267 Q9BV73 11190 CEP250 CEP2 CNAP1 Melanoma Phosphorylation N S2322 Q9BV73 11190 CEP250 CEP2 CNAP1 Melanoma Ubiquitination N K2327 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Phosphorylation N S2332 Q9BV73 11190 CEP250 CEP2 CNAP1 Bladder urothelial carcinoma Ubiquitination N K2347 Q9BV73 11190 CEP250 CEP2 CNAP1 Kidney renal clear cell carcinoma Phosphorylation N Y2373 Q9BV73 11190 CEP250 CEP2 CNAP1 Pancreatic adenocarcinoma Phosphorylation N Y2373 Q9BV73 11190 CEP250 CEP2 CNAP1 Lung squamous cell carcinoma Phosphorylation N S2392 Q9BV73 11190 CEP250 CEP2 CNAP1 Lung squamous cell carcinoma Phosphorylation N S2394 Q9BV73 11190 CEP250 CEP2 CNAP1 Pheochromocytoma and Paraganglioma Phosphorylation N S2417 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Phosphorylation N T2419 Q9BV73 11190 CEP250 CEP2 CNAP1 Pheochromocytoma and Paraganglioma Phosphorylation N T2419 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Phosphorylation N S2421 Q9BV73 11190 CEP250 CEP2 CNAP1 Neuroendocrine tumor Phosphorylation N S2421 Q9BV73 11190 CEP250 CEP2 CNAP1 Pheochromocytoma and Paraganglioma Phosphorylation N S2421 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Phosphorylation N S2424 Q9BV73 11190 CEP250 CEP2 CNAP1 Pheochromocytoma and Paraganglioma Phosphorylation N S2424 Q9BV73 11190 CEP250 CEP2 CNAP1 Head and neck squamous cell carcinoma Phosphorylation N S2433 Q9BV73 11190 CEP250 CEP2 CNAP1 Kidney renal papillary cell carcinoma Phosphorylation N S2433 Q9BV73 11190 CEP250 CEP2 CNAP1 Rectum adenocarcinoma Phosphorylation N S2433 Q9BV73 11190 CEP250 CEP2 CNAP1 Kidney renal papillary cell carcinoma Phosphorylation N T2437 Q9BV73 11190 CEP250 CEP2 CNAP1 Rectum adenocarcinoma Phosphorylation N T2437 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Stomach adenocarcinoma Phosphorylation N S9 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Stomach adenocarcinoma Phosphorylation N S11 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Stomach adenocarcinoma Phosphorylation N S12 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Colon adenocarcinoma Acetylation N K38 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Neuroendocrine tumor Phosphorylation N S117 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Skin cutaneous melanoma Phosphorylation C T121 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Pheochromocytoma and Paraganglioma Phosphorylation N T121 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Stomach adenocarcinoma Acetylation N K298 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Hepatocellular carcinoma Ubiquitination N K358 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Bladder urothelial carcinoma Ubiquitination N K389 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Hepatocellular carcinoma Phosphorylation N T445 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Hepatocellular carcinoma Ubiquitination N K447 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Hepatocellular carcinoma Phosphorylation N T448 Q9NQC1 23338 JADE2 KIAA0239 PHF15 Stomach adenocarcinoma Phosphorylation N S657 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Breast cancer breast cancer tissues Deubiquitination U 35102545 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Clear cell renal cell carcinoma ccRCC cell lines Hydroxylation U 30617181 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Cancer tumor tissue Acetylation U K512 36410688 Q99814 2034 EPAS1 BHLHE73 HIF2A MOP2 PASD2 Cancer tumor tissue Acetylation U K596 36410688 P29992 2767 GNA11 GA11 Uveal melanoma uveal melanoma tissues Palmitoylation U 35997986